First FRCR Examination – Clinical Pharmacology module
List of Anti-Cancer Drugs
This supporting document sets out a list of drugs expected to be covered during core clinical
oncology training and which may be included in the clinical pharmacology module of the First
FRCR examination. It is anticipated that this will be reviewed annually to ensure current
practice is reflected. This version will apply to examinations held from Autumn 2014 until a
further version is published.
Cytotoxic agents
Anti-Tumour Antibiotics
Actinomycin D / Dactinomycin
Alkylating agents
Bleomycin
Bendamustine
Daunorubicin
Busulfan
Doxorubicin
Carmustine
Doxorubicin (pegylated liposomal)
Chlorambucil
Epirubicin
Cyclophosphamide
Idarubicin
Dacarbazine
Mitomycin
Ifosfamide
Mitoxantrone
Melphalan
Procarbazine
Plant Alkaloids/ Microtubule Inhibitors
Etoposide
Streptozocin
Docetaxel
Temozolomide
Irinotecan
Anti- Metabolites
Paclitaxel
Asparaginase
Capecitabine
Topotecan
Vinblastine
Cytarabine
Vincristine
5- Fluoro Uracil
Vinorelbine
Fludarabine
Gemcitabine
DNA Linking Agents
Carboplatin
Methotrexate
Cisplatin
Pemetrexed
Raltitrexed
Oxaliplatin
November 2012 ‐ p1